This is comedy central. AIM-listed Proxama (PROX) put out an RNS after-hours last night (at 5.29pm) entitled Statement re Speculation and then ‘fessed up to a few problems at Companies House. I haven’t tracked down the speculation – perhaps some kind reader can point us all in the right direction. But well-run companies don’t suffer from this type of problem. The RNS read:

Shares in Dillistone Group (DSG) are currently more than 20% ahead, heading towards 80p, on the back of a Trading Update & Notice of Results announcement… but then they were also approaching 100p around a year ago, so what’s the story here?...

Hello, Share Seekers. I have a bigger holding than is safe with BP (BP.), but I don't think I’m going to sell any for some time. Which is a bit of a silly statement to make as, just like any other company, the story could change at any time. But BP has ridden out the storm of compensation. And though the fight isn’t over yet, I think share shifters like us need not worry too much. This is a huge company which can absorb most shocks.

In today's podcast I start with a follow up on Steve's excellent piece on Gattaca (GATC) where the COO is surely an insider dealer like Yosi Fait but as with Yosi nothing will happen as London regulation is a joke.  Then I look at IQE after today's bombshell from Muddy Waters (see HERE). Those who lost cash deserved to for ignoring so many prior warnings. I only celebrate the losses suffered by some of them. 

Legendary US bear raiding outfit Muddy Waters has announced that it is short of IQE (IQE). It dismisses Matt Earl's Shadowfall dossier of last week as only partially getting there and has published its own devastating report slating IQE as an "egregious accounting manipulator". Don't mess with Muddy Waters, anyone out there still owning this stock should sell NOW!. Muddy notes:

Shares in Nanoco Group (NANO) are currently racing ahead on the back of a Material Development and Supply Agreement announcement, with a sub-heading; “New partnership includes infrastructure investment, development, milestones and commercial supply agreement”. So, what’s the detail?...

Further to my pieces on the BMR Scandal, we might note that BMR completed a Placing via those fine upstanding chaps at Peterhouse Corporate Finance to raise £0.8 million at 2p, as announced on 14 November last year. This was, of course, when BMR knew – but the market did not – that it had received a default notice regarding its Kabwe project in Zambia.

Of course the title is a nod to the sad passing of music legend Mark E Smith a couple of weeks ago...but given the demographic of readers on this website I expect many of you are familiar with his 1981 penned epic which so famously was also used in The Silence of the Lambs. As one wag put it in a YouTube comment 'i find its (sic) the perfect song to play when you're being chased through your dungeon-like basement by an FBI special agent'. Absolutely! Anyhow...back to finance and investments.

Well, well. Yesterday AIM-listed BMR ‘fessed up that it had received a default notice way back in September from the Zambian authorities with reference to its Kabwe project. The company didn’t notify the market of that until yesterday, when it ‘fessed up that it has now been stripped of the license. So what of its joint venture partner, fellow AIM-listed Jubilee Metals Group (formerly Jubilee Platinum, JLP): what did it know?

As it happens, I reckon that Falanx (FLX) shares, which we own, are a stand out buy as well after yesterday's superb news. My thoughts will follow in due course. First up is the joint broker, Beaufort, with its thoughts and its video interview with boss Mike Read. 

Remember the fraud Cloudtag (CTAG), booted off AIM after its Nomad quit after it told just one too many total lies? Perhaps this is a spoof but it seems that fitness bands are not the place to be, Cloudtag is getting into blockchain. Natch! 

Given the administrators bombshell report into the demise of Ariadne HERE, the administrator's shocking report into the demise of Taggstar HERE and all the other shocking exposes on Julie Meyer we have run HERE would you be rushing to hand this woman any of your cash? But it seems she wants it. 

On 17th January Gattaca (GATC) noted “the recent share price fall” and responded that there would be a “minimal” impact of Carillion's liquidation on its balance sheet and that a “trading update for the six months ended 31st January will be released 8th February 2018”. However, at 2:30pm yesterday there were Trading Update and Directorate Change announcements. Hmmm…

I can understand why longer term investors in Parkmead Group (PMG) may be somewhat unimpressed with the performance of the share price recently, but the company itself is continuing to make good progress. I hold shares in the company myself, and whilst the share price has generally been trading in the mid-30p to low-40p range, in spite of the strength that the oil price has been showing in recent months, I’m happy to remain invested and see how things unfold in the coming months and years.

Hello, Share Plungers. Much as it makes me uncomfortable to contradict the mighty wisdom of my fellow scribe here, Lucian, I have to disagree with his advice against bargain-hunting Capita (CPI).

AIM-listed BMR updated the market at 1.15 this afternoon: it has been stripped of its Zambian Mining right and the shares are now suspended. And it seems the threat was known back in September, but the company didn’t bother to mention it.

Specialist supplier of colour cosmetics and owner of the W7 brand, Warpaint London (W7L) “is pleased” to update that it “continued to perform well during 2017 and the board confirms that it expects to report results in line with management expectations for the financial year” and that “2018 has started well and we look forward to the future with confidence”. But what are the expectations – and how do they compare to a current just over 200p share price?...

I start with why this bearcast is late. I got back very late from London where I was watching my daughter play Harold Wilson in Made in Dagenham and she was brilliant. So too was the musical. Well done Olaf although you are wrong about the gender pay gap! I look at the market bounce and the shit that is leading it. I look in  real detail at the trading statement at Reach4Entertainment (R4E) where I am a shareholder, at Woodford dog RM2 (RM2) which is going on a one way trip to the vets in a fortnight and also at Woodford Patient Capital Trust (WPCT). Post bearcast it announced its NAV at 85.93p which means gearing must surely be through the 20% barrier. I also look at Optibiotix (OPTI) and the warrant exercise issue.

Sensor systems technologies company Transense (TRT) has announced results for its half year ended 31st December 2017, including emphasising “significant market traction for both tyre probes and the iTrack II system for mine haul trucks”. Sounds encouraging…

You will have read our detailed coverage of Neil Woodford's woes and especially those of his uber dog listed investment company Woodford Patient Capital Trust (WPCT). Our sell advice has saved our readers thousands of pounds. But we believe in balance and so below is the advice of The Times Tempus column which is to buy. It is poorly researched - compare its coverage of Atom Bank with ours HERE) for instance and reads as if it was dictated by a PR person as is so often the case with the stinking carcass that is the deadwood press. Here goes...